Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
However, some manufacturer savings programs and discounts may not apply to off-label use
The fully reviewed version will be posted as soon as it is available
Canning P, Sorrell FJ, Bullock AN
It started as a volunteer project in 2014
Farxiga/Forxiga (dapagliflozin) Disease area(s): Metabolic diseases Manufacturer(s): AstraZeneca 2024 Sales (USD): $7.72 billion Why it sold so well: In 2024, AstraZenecas Farxiga achieved robust sales growth, with revenues increasing by 21% year-over-year to $1.9 billion in the fourth quarter alone and by 28% compared to 2023, making it the companys top seller in 2024
Non-Invasive Treatment Achieve a defined appearance without surgery or downtime
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
.webp)
